|
Re: So I was able to finally set up a one on one meeting with...
|
9
|
Resverlogix Corp.
|
Mar 15, 2022 03:09AM
|
|
Re: Apabetalone’s Positive Impact on Pulmonary Arterial Hypertension Published in the American Journal of Respiratory and Critical Care Medicine
|
17
|
Resverlogix Corp.
|
Mar 17, 2022 04:31PM
|
|
Re: Apabetalone’s Positive Impact on Pulmonary Arterial Hypertension Published in the American Journal of Respiratory and Critical Care Medicine
|
9
|
Resverlogix Corp.
|
Mar 18, 2022 12:24PM
|
|
Was checking out SEDAR...
|
6
|
Zenith Epigenetics
|
Mar 28, 2022 02:40PM
|
|
Re: Covid China
|
11
|
Resverlogix Corp.
|
Mar 30, 2022 01:46PM
|
|
Re: Was checking out SEDAR...
|
7
|
Zenith Epigenetics
|
Mar 30, 2022 01:56PM
|
|
Re: Debt
|
7
|
Zenith Epigenetics
|
Apr 05, 2022 08:47PM
|
|
Veru vs Resverlogix
|
17
|
Resverlogix Corp.
|
Apr 13, 2022 12:51PM
|
|
Re: Sabizabulin - mCRPC- used now for Covid 19.
|
6
|
Zenith Epigenetics
|
Apr 13, 2022 01:01PM
|
|
Re: Veru vs Resverlogix
|
11
|
Resverlogix Corp.
|
Apr 15, 2022 07:26PM
|
|
Re: Sabizabulin - mCRPC- used now for Covid 19.
|
4
|
Zenith Epigenetics
|
Apr 16, 2022 02:06PM
|
|
Re: Exempt Distribution - 2022-04-14
|
4
|
Resverlogix Corp.
|
Apr 18, 2022 11:38AM
|
|
Re: Sabizabulin - mCRPC- used now for Covid 19.
|
4
|
Zenith Epigenetics
|
Apr 18, 2022 11:51AM
|
|
Re: Sabizabulin - mCRPC- used now for Covid 19.
|
4
|
Zenith Epigenetics
|
Apr 18, 2022 12:02PM
|
|
Re: Resverlogix Announces One-Year Extension of Debenture
|
8
|
Resverlogix Corp.
|
Apr 21, 2022 10:50AM
|
|
Re: Sabizabulin - mCRPC- used now for Covid 19.
|
6
|
Zenith Epigenetics
|
Apr 21, 2022 11:09AM
|
|
Re: Sabizabulin - mCRPC- used now for Covid 19.
|
2
|
Zenith Epigenetics
|
Apr 23, 2022 04:22PM
|
|
Re: BTD
|
10
|
Resverlogix Corp.
|
Apr 23, 2022 04:53PM
|
|
Re: New Apabetalone Fabry Disease Publication
|
10
|
Resverlogix Corp.
|
Apr 26, 2022 05:15PM
|
|
Re: New Apabetalone Fabry Disease Publication
|
8
|
Resverlogix Corp.
|
Apr 29, 2022 12:29PM
|
